Table 2.
Requirement for additional circular support regimens during perioperation.
| Levosimendan (n = 20) | Non-levosimendan (n = 20) | p-value | |
|---|---|---|---|
| INTRAOPERATIVE MEDICAL CIRCULAR SUPPORT | |||
| * Dopamine, n (%) | All | All | — |
| * Dobutamine, n (%) | 18 (90) | 15 (75) | 0.407 |
| * Epinephrine, n (%) | 19 (95) | 13 (65) | 0.044 |
| * Norepinephrine, n (%) | 4 (20) | 2 (10) | 0.661 |
| * Milrinone, n (%) | 14 (70) | 14 (70) | 1.000 |
| * Vasopressin, n (%) | Null | Null | — |
| POSTOPERATIVE MEDICAL CIRCULAR SUPPORT | |||
| * Dopamine, n (%) | All | All | — |
| * Dobutamine, n (%) | 20 (100) | 17 (85) | 0.231 |
| * Epinephrine, n (%) | 20 (100) | 17 (85) | 0.231 |
| * Norepinephrine, n (%) | 2 (10) | 2 (10) | 1.000 |
| * Milrinone, n (%) | 18 (90) | 18 (90) | 1.000 |
| * Vasopressin, n (%) | 4 (20) | 0 (0) | 0.106 |